Drugdu.com expert's response:

Medical device export testing and certification requirements are not determined by “export” as a general concept. They mainly depend on the target market + product category + risk classification. The same product may face very different requirements when exported to the EU, the United States, the UK, or Southeast Asia.

Generally, the requirements can be assessed from the following aspects:

I. Basic General Requirements

1. ISO 13485 Quality Management System Certification

ISO 13485 is one of the most common quality management system certifications for medical device companies. It is often recognized by overseas customers, registration authorities, and procurement channels.

It is not a “market access certificate” for every country, but it is usually an important basic document for medical device export. ISO 13485 focuses on whether the company has established a quality management system that meets medical device regulatory requirements, including design and development, production control, risk management, traceability, and document records.

2. Product Test Reports

Product test reports usually cover safety, performance, reliability, electrical safety, biological compatibility, sterilization validation, packaging and transportation validation, software validation, and other items, depending on the product type.

For example, active medical devices usually involve electrical safety and electromagnetic compatibility testing, while sterile consumables often involve sterilization, biological compatibility, and packaging integrity.

3. Technical Documentation / Registration Dossier

Common documents include instructions for use, labels, risk management reports, clinical evaluation materials, performance test reports, raw material information, production processes, quality control documents, adverse event information, and post-market surveillance materials.

II. Common Market Access Requirements in Major Markets

EU: CE / MDR or IVDR

General medical devices are mainly subject to the MDR, while in vitro diagnostic devices are subject to the IVDR.

For low-risk Class I products, manufacturers can usually complete the declaration of conformity and affix the CE marking by themselves. For Class IIa, IIb, and III products, a notified body is usually required to participate in the conformity assessment.

The EU now has significantly higher requirements for clinical evidence, post-market surveillance, UDI traceability, and related documentation.

United States: FDA Establishment Registration, Device Listing, 510(k), or PMA

Access to the U.S. market depends on the FDA classification of the device.

Most Class I devices require establishment registration and device listing. Many Class II devices require a 510(k) premarket notification. Class III high-risk devices usually require PMA, or Premarket Approval.

The pathway varies greatly by product, so it should not be simply understood as “obtaining an FDA certificate.”

UK: UKCA / CE Transitional Requirements

The UK market involves UKCA marking and UK-approved conformity assessment bodies. For Northern Ireland, CE rules still apply.

According to UK official guidance, devices placed on the Northern Ireland market and circulated in the EU still need CE marking and may require the involvement of an EU-recognized notified body.

Domestic Compliance in China as an Export Basis

If the product is manufactured and sold in China, it may also involve NMPA registration or filing.

China classifies medical devices into Class I, II, and III according to risk. Class I devices are subject to filing, while Class II and III devices require registration.

Although domestic registration does not equal overseas market access, many overseas customers will still regard domestic qualifications, production licenses, and test reports as part of supplier review materials.

III. Common Testing Directions for Different Product Types

Medical consumables: biocompatibility, sterility or microbial limits, ethylene oxide residue, packaging integrity, transportation validation, and material safety.

Active medical devices: electrical safety, EMC, software validation, performance testing, risk management, and compliance of instructions for use and labels.

IVD products: analytical performance, clinical performance, stability, batch-to-batch consistency, quality control system, IVDR documentation, or target-country IVD registration materials.

Implantable or high-risk devices: biocompatibility, clinical evaluation or clinical trials, long-term safety, risk management, and post-market surveillance materials.